What is iRadimed's total devices revenue — total revenue?

iRadimed (IRMD) reported total devices revenue — total revenue of $15.39M in Q1 2026.

What does total devices revenue — total revenue mean?

This metric represents the portion of total net revenue generated specifically from the sale of hardware units, such as MRI-compatible infusion pumps and patient monitoring systems. It serves as a key indicator of the company's core product adoption and market penetration within hospitals and acute care facilities. Tracking this revenue stream helps investors assess the company's ability to drive growth through new equipment installations versus recurring service or accessory sales.

iRadimed (IRMD) Total devices revenue — Total Revenue

Screener

Other product segments

MRI Compatible IV Infusion Pumps

$7.66M+27.8%

MRI Compatible Patient Vital Signs Monitoring Systems

$7.11M+8.6%

Disposables

$4.89M—

Services and other

$1.04M—

Amortization of extended maintenance agreements

$659K—

Ferro Magnetic Detection Systems

$621K+48.6%

Similar metrics at other companies

IBRXOther revenues — Total Revenue

$39K+388%

MDBServices — Total Revenue

$21.48M+22.3%

GWREServices — Total Revenue

$71.81M+31.9%

ESTCServices — Total Revenue

$28.24M+5.8%

IRDMServices — Total Revenue

$161.33M+3.7%

DDDServices — Total Revenue

$37.77M-5.1%

Other financials

Income statement

See full

Revenue$22.0M+12.6%

Gross profit$16.8M+13.3%

Operating income$7.2M+33.2%

Net income$5.8M+24.1%

EPS (diluted)$0.45+21.6%

Balance sheet

See full

Cash & equivalents$56.4M+12.0%

Total debt$59.2K-96.9%

Total equity$98.5M+9.4%

Total assets$114.4M+12.4%

Cash flow

See full

Operating cash flow$8.3M+93.2%

CapEx$403.0K-89.1%

Free cash flow$7.9M+1,226%

Valuation

See full

Market cap$1.17B+30.4%

P/E49.4×+6.1×

P/S13.5×+2.0×

Profitability

See full

Gross margin76.8%-0.1pp

Operating margin32.4%+2.3pp

Net margin27.4%+1.0pp

FCF margin28.4%+8.9pp

Returns & leverage

See full

Return on equity25%+1.2pp

Debt / equity0×0.0×

Current ratio7.1×-1.7×

Where this comes from

Reported directly by iRadimed in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: iRadimed’s 10-Q, filed May 1, 2026.

Filed: May 1, 2026, 4:08 PM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0001628280-26-029325

Line item	Three Months Ended March 31, 2026	Three Months Ended March 31, 2025
MRI Compatible Intravenous ("IV") Infusion Pump Systems	$7,664	$5,999
MRI Compatible Patient Vital Signs Monitoring Systems	7,107	6,545
Ferro Magnetic Detection Systems	621	418
Total devices revenue	15,392	12,962
Amortization of extended maintenance agreements	659	560
Disposables	4,885	4,947
Services and other	1,043	1,042
Total revenue	$21,979	$19,511

Item 1. Condensed Financial Statements

FAQ

What is iRadimed's total devices revenue — total revenue?: iRadimed (IRMD) reported total devices revenue — total revenue of $15.39M in Q1 2026.
What does total devices revenue — total revenue mean?: This metric represents the portion of total net revenue generated specifically from the sale of hardware units, such as MRI-compatible infusion pumps and patient monitoring systems. It serves as a key indicator of the company's core product adoption and market penetration within hospitals and acute care facilities. Tracking this revenue stream helps investors assess the company's ability to drive growth through new equipment installations versus recurring service or accessory sales.